Molecular targeted therapies of aggressive thyroid cancer

Differentiated thyroid carcinomas (DTC) that arise from follicular cells account > 90% of thyroid cancer (TC) [papillary thyroid cancer (PTC) 90%, follicular thyroid cancer (FTC) 10%], while medullary thyroid cancer (MTC) accounts < 5%. Complete total thyroidectomy is the treatment of choice for PTC...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Silvia Martina eFerrari, Poupak eFallahi, Ugo ePolitti, Gabriele eMaterazzi, Enke eBaldini, Salvatore eUlisse, Paolo eMiccoli, Alessandro eAntonelli
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2015-11-01
Цуврал:	Frontiers in Endocrinology
Нөхцлүүд:	Papillary thyroid cancer vandetanib Sorafenib Medullary Thyroid Cancer Follicular thyroid cancer Cabozantinib
Онлайн хандалт:	http://journal.frontiersin.org/Journal/10.3389/fendo.2015.00176/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!